Skip to main content

Judith Sacanell Lacasa

Institutions of which they are part

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Vall Hebron Institut de Recerca

Judith Sacanell Lacasa

Institutions of which they are part

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Vall Hebron Institut de Recerca

Projects

ADN CIRCULANTE COMO BIOMARCADOR NO INVASIVO TRAS UN TRASPLANTE DE PULMÓN

IP: Antonio Román Broto
Collaborators: Carles Bravo Masgoret, Vanessa Casares Rodríguez, Judith Sacanell Lacasa, Cristina Berastegui Garcia, Manuel López Meseguer, Berta Saez Gimenez, Maria Martinez Martinez, Jordi Riera del Brío
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI17/01485
Duration: 01/01/2018 - 30/06/2022

Papel del eje IL-33 /ST2 en el diagnóstico, pronóstico y tratamiento del Síndrome de distrés respiratorio agudo

IP: -
Collaborators: César Laborda Soriano, Judith Sacanell Lacasa
Funding agency: Instituto de Salud Carlos III
Funding: 122815
Reference: PI14/01420
Duration: 01/01/2015 - 31/12/2017

Grup de Recerca en Sèpsia i Infecció Respiratoria Greu

IP: Grup de Recerca en Sèpsia i Infecció Respiratoria Greu
Collaborators: Elisabet Gallart Vive, Rosa Maria Gracia Gozalo, Juan Carlos Ruiz Rodriguez, Judith Sacanell Lacasa, Marcos Pérez Carrasco, Joan Balcells Ramírez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2009 SGR 1226
Duration: 01/01/2010 - 30/04/2014

Insuficienca respiratoria aguda (disfunción primaria del injerto y neumonía vs rechazo) en el postoperatorio en UCI del trasplante pulmonar (UCI-TRASP)

IP: -
Collaborators: Roser Anglès Coll, María Deu Martín, Judith Sacanell Lacasa, Jordi Riera del Brío, Teresa Pont Castellana
Funding agency: Instituto de Salud Carlos III
Funding: 222541.99
Reference: PI11/01122
Duration: 01/01/2012 - 31/12/2014

Related news

The study will be conducted in the Intensive Care Medicine Service of the Vall d’Hebron University Hospital and will validate the prognostic value of the NLRP3 biomarker.

SOFA-2 is being updated after thirty years to incorporate advances in diagnosis, monitoring and life support.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

Related professionals

Laura Hidalgo Corbacho

Laura Hidalgo Corbacho

Predoctoral researcher
Diabetes and Metabolism
Read more
Monica Carreras Burrull

Monica Carreras Burrull

Gestió i Administració
Commercial and Academic Clinical Research
Read more
Alba Gil Loyo

Alba Gil Loyo

Research technician
Ophtalmology
Read more
Pere López Gutierrez

Pere López Gutierrez

Research technician
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.